Roche Holding AG will maintain a strategy of “targeted acquisitions” and isn’t seeking a mega- merger, Chief Executive Officer Severin Schwan said in comments that may rule out a bid for Abbott Laboratories’ prescription- drug spinoff.
Roche Holding AG and Merck & Co. will work together to market treatments for hepatitis C in the U.S., promoting Merck’s new boceprevir with an older drug from Roche in a market estimated to reach $15 billion annually by 2019.
Roche Holding AG, the world’s biggest maker of cancer drugs, forecast high single-digit percentage growth in earnings per share this year, disappointing some investors as new products start to contribute to sales.
Charles Plosser, president of the Federal Reserve Bank of Philadelphia, said the Fed will probably need to raise interest rates before mid-2013 and that policy makers should have waited to see how the economy performed before pledging to hold rates at record lows for two years.
Roche Holding AG’s top-seller Avastin didn’t slow breast tumors in new studies as much as in earlier tests used to win approval, according to U.S. regulators weighing whether to permit sales to continue for this purpose.